Related references
Note: Only part of the references are listed.Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Luca Malorni et al.
MOLECULAR CANCER RESEARCH (2016)
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer
Nathalie Quenel-Tueux et al.
BRITISH JOURNAL OF CANCER (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage
Chi-Hsuan Chang et al.
STEM CELL REPORTS (2015)
FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
C. Gong et al.
ONCOGENE (2015)
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
Gladys Morrison et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
J. L. L. Robinson et al.
ONCOGENE (2014)
Switch in FOXA1 Status Associates with Endometrial Cancer Progression
Ingvild Loberg Tangen et al.
PLOS ONE (2014)
Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their Paired Lymph Node Metastases
Marieke A. Vollebergh et al.
PLOS ONE (2014)
MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer
Ross M. Drayton et al.
ONCOTARGET (2014)
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase
Xiaoyong Fu et al.
BREAST CANCER RESEARCH (2014)
Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer
Xiaoyong Fu et al.
BREAST (2013)
Molecular Profiling of Aromatase Inhibitor-Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Anita K. Dunbier et al.
CLINICAL CANCER RESEARCH (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
FOXA1 represses the molecular phenotype of basal breast cancer cells
G. M. Bernardo et al.
ONCOGENE (2013)
Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production
Yi Zhang et al.
PLOS ONE (2013)
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
Luca Magnani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells
Jagdeep K. Singh et al.
BREAST CANCER RESEARCH (2013)
FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
Josefine Gerhardt et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data
Jianxing Feng et al.
BIOINFORMATICS (2012)
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Rutika J. Mehta et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer
Adrian Britschgi et al.
CANCER CELL (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression
Richard Cowper-Sal-lari et al.
NATURE GENETICS (2012)
Identifying ChIP-seq enrichment using MACS
Jianxing Feng et al.
NATURE PROTOCOLS (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
Christine L. Clarke et al.
PLOS ONE (2012)
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
Jessica D. Kessler et al.
SCIENCE (2012)
Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
Chunpeng Zhang et al.
CANCER RESEARCH (2011)
Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase Inhibitors
Angela Brodie et al.
CLINICAL CANCER RESEARCH (2011)
High-level expression of forkhead-box protein A1 in metastatic prostate cancer
Rohit K. Jain et al.
HISTOPATHOLOGY (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
Kristen L. Meerbrey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Detection of Somatic Copy Number Alterations in Cancer Using Targeted Exome Capture Sequencing
Robert J. Lonigro et al.
NEOPLASIA (2011)
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers - role of estrogen receptor and HER2 reactivation
Yen-Chao Wang et al.
BREAST CANCER RESEARCH (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance
Mathieu Lupien et al.
GENES & DEVELOPMENT (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Expression of Forkhead- box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
Foluso O. Ademuyiwa et al.
MODERN PATHOLOGY (2010)
Alternative expression analysis by RNA sequencing
Malachi Griffith et al.
NATURE METHODS (2010)
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER plus breast cancer
Chad J. Creighton et al.
BREAST CANCER RESEARCH (2010)
CEAS: cis-regulatory element annotation system
Hyunjin Shin et al.
BIOINFORMATICS (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma
Carmelo Nucera et al.
CLINICAL CANCER RESEARCH (2009)
Pathway Biomarker Profiling of Localized and Metastatic Human Prostate Cancer Reveal Metastatic and Prognostic Signatures
Robert L. Grubb et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Integrated analysis of breast cancer cell lines reveals unique signaling pathways
Laura M. Heiser et al.
GENOME BIOLOGY (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts
Chad J. Creighton et al.
CANCER RESEARCH (2008)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival
Sunil Badve et al.
CLINICAL CANCER RESEARCH (2007)
Positive cross-regulatory loop ties GATA-3 to estrogen receptor α expression in breast cancer
Jerome Eeckhoute et al.
CANCER RESEARCH (2007)
Genome-wide analysis of estrogen receptor binding sites
Jason S. Carroll et al.
NATURE GENETICS (2006)
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Stephen Hiscox et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Java Treeview-extensible visualization of microarray data
AJ Saldanha
BIOINFORMATICS (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The role of hepatocyte nuclear factor-3α (forkhead box A1) and androgen receptor in transcriptional regulation of prostatic genes
N Gao et al.
MOLECULAR ENDOCRINOLOGY (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo
R Schiff et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
